Environmental influences have profound yet reversible effects on the behavior of resident cells. Earlier data have indicated that the amount of muscle formed from implanted myogenic cells is greatly augmented by prior irradiation (18 Gy) of the host mouse muscle. Here we confirm this phenomenon, showing that it varies between host mouse strains. However, it is unclear whether it is due to secretion of proliferative factors or reduction of antiproliferative agents. To investigate this further, we have exploited the observation that the immortal myogenic C2 C12 cell line forms tumors far more rapidly in irradiated than in nonirradiated host muscle. We show that the effect of preirradiation on tumor formation is persistent and dose dependent. However, C2 C12 cells are not irreversibly compelled to form undifferentiated tumor cells by the irradiated muscle environment and are still capable of forming large amounts of muscle when reimplanted into a nonirradiated muscle. In a clonal analysis of this effect, we discovered that C2 C12 cells have a bimodal propensity to form tumors; some clones form no tumors even after extensive periods in irradiated graft sites, whereas others rapidly form extensive tumors. This illustrates the subtle interplay between the phenotype of implanted cells and the factors in the muscle environment.
Skip Nav Destination
Article navigation
13 May 2002
Article|
May 13 2002
Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site
Jennifer E. Morgan,
Jennifer E. Morgan
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
Search for other works by this author on:
Jacqueline G. Gross,
Jacqueline G. Gross
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
Search for other works by this author on:
Charles N. Pagel,
Charles N. Pagel
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
Search for other works by this author on:
Jonathan R. Beauchamp,
Jonathan R. Beauchamp
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
Search for other works by this author on:
Ariberto Fassati,
Ariberto Fassati
2Wohl Virion Centre, Windeyer Institute, University College London Medical School, London W1T, UK
Search for other works by this author on:
Adrian J. Thrasher,
Adrian J. Thrasher
3Molecular Immunology Unit, Institute of Child Health, London WC1N 1EH, UK
Search for other works by this author on:
James P. Di Santo,
James P. Di Santo
4Unité des Cytokines et Développement Lymphoide, INSERM EMI-0101, Département d'Immunologie, Institut Pasteur, 75724 Paris, France
Search for other works by this author on:
Ivan B. Fisher,
Ivan B. Fisher
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
5Department of Rheumatology, Division of Medicine, Royal Free and University College Medical School, London NW3 2PF, UK
6Department of Paediatrics and Neonatal Medicine, Imperial College School of Technology and Medicine, London W12 ONN, UK
Search for other works by this author on:
Xu Shiwen,
Xu Shiwen
5Department of Rheumatology, Division of Medicine, Royal Free and University College Medical School, London NW3 2PF, UK
Search for other works by this author on:
David J. Abraham,
David J. Abraham
5Department of Rheumatology, Division of Medicine, Royal Free and University College Medical School, London NW3 2PF, UK
Search for other works by this author on:
Terence A. Partridge
Terence A. Partridge
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
Search for other works by this author on:
Jennifer E. Morgan
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
Jacqueline G. Gross
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
Charles N. Pagel
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
Jonathan R. Beauchamp
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
Ariberto Fassati
2Wohl Virion Centre, Windeyer Institute, University College London Medical School, London W1T, UK
Adrian J. Thrasher
3Molecular Immunology Unit, Institute of Child Health, London WC1N 1EH, UK
James P. Di Santo
4Unité des Cytokines et Développement Lymphoide, INSERM EMI-0101, Département d'Immunologie, Institut Pasteur, 75724 Paris, France
Ivan B. Fisher
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
5Department of Rheumatology, Division of Medicine, Royal Free and University College Medical School, London NW3 2PF, UK
6Department of Paediatrics and Neonatal Medicine, Imperial College School of Technology and Medicine, London W12 ONN, UK
Xu Shiwen
5Department of Rheumatology, Division of Medicine, Royal Free and University College Medical School, London NW3 2PF, UK
David J. Abraham
5Department of Rheumatology, Division of Medicine, Royal Free and University College Medical School, London NW3 2PF, UK
Terence A. Partridge
1Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, London W12 0NN, UK
Address correspondence to Jennifer E. Morgan, Muscle Cell Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College School of Technology and Medicine, Hammersmith Hospital Campus, Du Cane Road, London W12 ONN, UK. Tel.: 02-08-383-8262. Fax: 02-08-383-8264. E-mail: [email protected]
*
Abbreviations used in this paper: FGF, fibroblast growth factor; MMP, matrix metalloproteinase; MPC, muscle precursor cell; TA, tibialis anterior.
Received:
August 09 2001
Revision Received:
March 28 2002
Accepted:
April 02 2002
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2002
J Cell Biol (2002) 157 (4): 693–702.
Article history
Received:
August 09 2001
Revision Received:
March 28 2002
Accepted:
April 02 2002
Citation
Jennifer E. Morgan, Jacqueline G. Gross, Charles N. Pagel, Jonathan R. Beauchamp, Ariberto Fassati, Adrian J. Thrasher, James P. Di Santo, Ivan B. Fisher, Xu Shiwen, David J. Abraham, Terence A. Partridge; Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site . J Cell Biol 13 May 2002; 157 (4): 693–702. doi: https://doi.org/10.1083/jcb.200108047
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement